BP1-7 therapeutic vaccine: Will start a Phase I safety trial in 14 patients

Biomira Inc. (BIOMF), Edmonton, Alberta Product: BP1-7 therapeutic vaccine, consisting of a 16 amino acid sequence from a glycoprotein marker, MUC-1, on the surface of adenocarcinoma cells Indication:...